Stonepine Capital Management, LLC is an institution, managing $123.0M across 58 long positions as of Q3 2025 with 97% Healthcare concentration, 62% concentrated in top 10 holdings, and 19% allocation to VSTM.
Largest long holdings in Stonepine Capital Management, LLC's portfolio (62.1% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $23.6M | 19.17% | +$11.6M Bought | 4.34% 2.7M shares | |
Biotechnology Healthcare | $10.8M | 8.81% | -$161.3K Sold | 0.31% 739.0K shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $9.4M | 7.67% | +$3.8M Bought | 2.38% 1.5M shares | |
Biotechnology Healthcare | $7.7M | 6.26% | +$327.0K Bought | 1.44% 810.0K shares | |
Biotechnology Healthcare | $4.8M | 3.93% | +$2.0M Bought | 0.45% 85.0K shares | |
Biotechnology Healthcare | $4.6M | 3.71% | +$1.4M Bought | 0.63% 647.4K shares | |
Biotechnology Healthcare | $4.4M | 3.62% | -$1.4M Sold | 0.96% 115.5K shares | |
Biotechnology Healthcare | $3.7M | 3.03% | -$1.1M Sold | 0.10% 174.5K shares | |
Biotechnology Healthcare | $3.7M | 2.97% | -$3.6M Sold | 1.43% 305.0K shares | |
Biotechnology Healthcare | $3.6M | 2.94% | +$3.6M Bought | 4.71% 1.1M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Stonepine Capital Management, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for Stonepine Capital Management, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.